发明名称 Detecting and classifying copy number variation in a cancer genome
摘要 Attorney Docket No. 01 18.504WO The invention provides a method for determining copy number variations (CNV) of a sequence of interest in a test sample that comprises a mixture of nucleic acids that are known or are suspected to differ in the amount of one or more sequence of interest. The method comprises a statistical approach that accounts for accrued variability stemming from process-related, interchromosomal and inter-sequencing variability. The method is applicable to determining CNV of any fetal aneuploidy, and CNVs known or suspected to be associated with a variety of medical conditions. CNV that can be determined according to the method include trisomies and monosomies of any one or more of chromosomes 1-22, X and Y, other chromosomal polysomies, and deletions and/or duplications of segments of any one or more of the chromosomes, which can be detected by sequencing only once the nucleic acids of a test sample.
申请公布号 AU2013204536(A1) 申请公布日期 2014.02.06
申请号 AU20130204536 申请日期 2013.01.30
申请人 VERINATA HEALTH, INC. 发明人 RAVA, RICHARD P.;CHINNAPPA, MANJULA;COMSTOCK, DAVID A.;SRINIVASAN, ANUPAMA
分类号 C12Q1/68 主分类号 C12Q1/68
代理机构 代理人
主权项
地址